http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-S1700032-I1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
filingDate | 2017-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | HU-S1700032-I1 |
titleOfInvention | Anti-cancer drug containing alpha, alpha, alpha-trifluoroimidine and thymidine phosphorylase inhibitor |
priorityDate | 2005-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 323.